Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients

NCT00150345 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Possible Fungal Infection

Interventions

DRUG: voriconazole (Vfend)
DRUG: voriconazole (Vfend)

Sponsor

Pfizer

Collaborators

[object Object]